Multiplexed Diagnostics Market to See 20% CAGR to 2018

DALLAS, October 17, 2014 /PRNewswire/ --

ReportsnReports.com adds Global Multiplexed Diagnostics Market 2014-2018 research report on equipments that are used for analyzing multiple analytes in the single cycle of the assay procedure. According to this research, the global multiplexed diagnostics market is set to grow at a CAGR of 20.05% over the period 2013-2018. Spread across 93 pages and published in October 2014, this report is available at http://www.reportsnreports.com/reports/300160-global-multiplexed-diagnostics-market-2014-2018.html .

The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing.

The Global Multiplexed Diagnostics Market 2014-2018 research report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Companies like Affymetrix, Agilent Technologies, Biomeurix, F. Hoffmann-La Roche, Illumina, Thermo Fisher Scientific, Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, Hologic, Luminex, Qaigen, Siemens Healthcare and ZOLL Medical are discussed in this research available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=300160 .

Key questions on multiplexed diagnostics market that this research helps answer are: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

List of Exhibits Provided in Global Multiplexed Diagnostics Market 2014-2018 Research Report: 

Exhibit 1: Market Research Methodology
Exhibit 2: Global Multiplexed Diagnostics Market 2013-2018 (US$ million)
Exhibit 3: Medium Density Multiplexed Assays Market by Technology Segmentation
Exhibit 4: Low Density Multiplexed Assays Market by Technology Segmentation
Exhibit 5: High Density Multiplexed Assays Market by Technology Segmentation
Exhibit 6: Very High Density Multiplexed Assays Market by Technology Segmentation
Exhibit 7: Global Multiplexed Diagnostics Market Segmentation by Technology 2013
Exhibit 8: Global Medium Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 9: Global Low Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 10: Global High Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 11: Global Very High Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 12: Global Next- Generation Sequencing Market 2013-2018 (US$ million)
Exhibit 13: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018
Exhibit 14: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018 (US$ million)
Exhibit 15: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013
Exhibit 16: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018
Exhibit 17: Multiplexed Diagnostics Market in the Americas 2013-2018 (US$ million)
Exhibit 18: Multiplexed Diagnostics Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 19: Multiplexed Diagnostics Market in the APAC Region 2013-2018 (US$ million)
Exhibit 20: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 21: Affymetrix: Business Segmentation 2013
Exhibit 22: Affymetrix: Business Segmentation by Revenue 2013
Exhibit 23: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 24: Affymetrix: Sales by Geography 2013
Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 30: Illumina: Business Segmentation 2013
Exhibit 31: Illumina: Sales by Geography 2013
Exhibit 32: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 33: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013 and 2012
Exhibit 34: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 35: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
Exhibit 37: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
Exhibit 38: Thermo Fisher Scientific: Sales by Geography 2013

Another research titled Global Intracranial Stents Market 2014-2018 forecasts the industry to grow at 18.75% CAGR during 2013-2018. Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. Aneurysm is a condition in which the artery widens and becomes weaker than a normal artery wall. Aneurysm is the result of high blood pressure and other factors such as aging, smoking, intracranial hypertension, and cerebrovascular complications. A type of aneurysm involving cerebral artery is called cerebral aneurysm or intracranial aneurysm. Intracranial stents help in strengthening the weakened artery, allowing smooth blood flow, without causing any effect to the bulge. These stents are used to treat cerebral-related strokes. Companies like Covidien, DePuy Synthes, Medtonic, MicroPort Scientific, OBEX Medical, Stryker, Abbott Laboratories, Admedes Schuessler, BALT Extrusion, Cardiatis and Penumbra are discussed in this research available at http://www.reportsnreports.com/reports/311225-global-intracranial-stents-market-2014-2018.html .

Explore more healthcare market reports as well as research studies on the medical devices industry at http://www.reportsnreports.com/market-research/medical-devices/ .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:  

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
sales@reportsandreports.com  

Connect With Us on:  

Facebook: https: //www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

Pinterest: www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http: //www.reportsnreports.com/feed/l-latestreports.xml